GeneDx Holdings (WGS) Share-based Compensation (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Share-based Compensation of $12.1 million for Q1 2026, up 203.44% year-over-year from $4.0 million in Q1 2025, and up 23.58% quarter-over-quarter from $9.8 million in Q4 2025.
GeneDx Holdings (WGS) Share-based Compensation (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Share-based Compensation for 7 consecutive years, with $12.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 203.44% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $40.3 million (up 196.68% YoY), while the FY2025 annual figure was $32.2 million, up 251.96% from the prior year.
- Share-based Compensation advanced to $12.1 million in Q1 2026 per WGS's latest filing, from $9.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $154.4 million in Q2 2022 and bottomed at -$130.0 million in Q4 2022.
- Historically, Share-based Compensation has averaged $6.0 million across 5 years, with a median of $3.8 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 29857.42% — and 2024, when it sank 1039.58%.
- GeneDx Holdings' Share-based Compensation stood at -$130.0 million in 2022, then jumped by 100.04% to $51000.0 in 2023, then jumped by 5478.43% to $2.8 million in 2024, then jumped by 243.76% to $9.8 million in 2025, then rose by 23.58% to $12.1 million in 2026.
- Business Quant data shows WGS's Share-based Compensation at $12.1 million in Q1 2026, $9.8 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 95.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 774,000.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.37 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 6.00 Mn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Jun 30, 2026 | 3.25 Mn |
| Mar 31, 2026 | 12.09 Mn |
| Mar 31, 2026 | 12.09 Mn |
| Dec 31, 2025 | 9.78 Mn |
| Dec 31, 2025 | 9.78 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Jun 30, 2025 | 7.81 Mn |
| Jun 30, 2025 | 7.81 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -451,000.00 |
| Mar 31, 2024 | -451,000.00 |